131
Views
3
CrossRef citations to date
0
Altmetric
COMMENTARY

Individual Patient Treatment Use of Unapproved Drugs: A New Option for the Seriously Ill

&
Pages 19-22 | Published online: 26 Mar 2010
 

ABSTRACT

A landmark 1997 U.S. Court of Appeals ruling on the right of an individual to use an unapproved drug had highlighted the controversy about this right. Subsequently, the Food and Drug Administration (FDA) authorized individual patient access to investigational new drugs though Treatment Investigational New Drugs (INDs). This commentary describes applicable law and issues that apply to the debate over individual patient access to unapproved drugs, including the issue of who should pay for the use of experimental drugs in patient care outside of a study.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 553.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.